About REMDANTRY

REMDANTRY is a prescription medication containing the active ingredient Infliximab, a chimeric monoclonal antibody that selectively binds to tumor necrosis factor-alpha (TNF-alpha). It is used to treat various autoimmune diseases by reducing inflammation and preventing tissue damage.

Key Benefits & Uses

Treatment of moderate to severe rheumatoid arthritis, including symptoms such as joint pain and swelling.
Treatment of ankylosing spondylitis, a type of arthritis that affects the spine and other joints.
Treatment of psoriatic arthritis, a condition that causes joint pain and swelling in people with psoriasis.
Treatment of Crohn's disease and ulcerative colitis, two types of inflammatory bowel disease.

Active Ingredient & Action

REMDANTRY's active ingredient, Infliximab, works by binding to TNF-alpha, a protein that promotes inflammation and tissue damage. By blocking TNF-alpha, Infliximab reduces inflammation and prevents tissue damage, thereby alleviating symptoms of autoimmune diseases.

Important Notes

REMDANTRY should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse effects. Patients with a history of infections, heart problems, or other medical conditions should inform their doctor before starting treatment with REMDANTRY.